Navigation Links
Omeros Announces Clinical Development Programs for OMS103HP and OMS302
Date:5/19/2011

SEATTLE, May 19, 2011 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it is advancing two of its product candidates from its PharmacoSurgery™ platform – OMS103HP for arthroscopic meniscectomy and OMS302 for intra-ocular lens replacement surgery – into Phase 3 clinical development programs. Both of these product candidates are added to standard irrigation solutions and delivered intra-operatively to the operative site throughout the surgical procedure to preemptively block the molecular-signaling and biochemical cascade caused by surgical trauma and to provide clinical benefits both during and after surgery.

"I am pleased to report today that we have already begun advancing Phase 3 clinical programs for OMS103HP and OMS302," stated Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros.  "Both of these drugs generated positive efficacy and safety data in large Phase 2 clinical trials and, based on our analysis of those data, we are optimistic that each drug's clinical benefits will be further demonstrated in its respective Phase 3 clinical program."

The OMS103HP Phase 3 clinical program will evaluate the drug's safety and efficacy in improving postoperative joint function and reducing pain following arthroscopic partial meniscectomy surgery. The program will consist of two randomized, double-blind, vehicle-controlled, multicenter trials to be conducted in North America and Europe. Omeros expects data from the North American trial in the first half of 2012. The Company is in discussions with European regulatory authorities regarding the second clinical trial and, assuming sufficient resources, plans to begin that trial during the fourth quarter of 2011. The primary endpoint for these trials will be performance on the Knee Injury and Osteoarthritis Outcome Score (KOOS), a validated patient-reported o
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros Corporation Reports First Quarter 2011 Financial Results
2. Omeros Announces Expansion of Potential Indications for PDE7 Inhibitors
3. Omeros Announces Publication of MASP-2 Data in Proceedings of the National Academy of Sciences
4. Omeros Reports Outcome of Phase 3 Trials of OMS103HP
5. Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results
6. Omeros Unlocks Orphan GPCRs Linked to Pancreatic Cancer and Cognitive Disorders
7. Omeros Announces Expansion of Exclusive License to PDE7 Inhibitors from Daiichi Sankyo
8. Omeros Announces Publication of Data From Antifibrinolytic Program
9. Omeros Licenses Novel Antifibrinolytic Agents
10. Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy
11. Omeros to Host Conference Call Monday, October 25 at 4:00 p.m. ET To Provide Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 30, 2014 ... addition of the  "Process Validation in the US ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,Key topics ... Based Approach to Process Validation for Pharmaceutical and ... FDA Process Validation Guidance EU ...
(Date:10/31/2014)... 31, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... , Isis Pharmaceuticals, Third Quarter 2014 Financial Results ... at 11:30 a.m. ET / 8:30 a.m. PTWhere: ... Internet. Simply log onto our website listed above. If ... a replay of the webcast will be available for ...
(Date:10/31/2014)... Ill., Oct. 31, 2014  AbbVie (NYSE: ... the third quarter ended Sept. 30, 2014. ... performance of our business with double-digit growth from ... business grew nearly 14 percent in the quarter ... chief executive officer, AbbVie.  "We exceeded our outlook ...
Breaking Medicine Technology:Process Validation in the US and EU (Workshop, London) 2Process Validation in the US and EU (Workshop, London) 3Process Validation in the US and EU (Workshop, London) 4Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 3AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24
(Date:10/31/2014)... cell division is central to life. The last stage, ... fascinated scientists since the dawn of cell biology in ... been notoriously difficult to study this final step, when ... two. , The name given to this process by ... captures the sense of a highly active and organized ...
(Date:10/31/2014)... of its kind, Rice University researchers have mapped how ... cells to become metastatic. The research reveals a common ... both migrate and form new tumors. Researchers say the ... interfere with the genetic switches that cancer must flip ... cells -- two of the main players in cancer ...
(Date:10/31/2014)... — A team from the Broad Institute, the ... California, Santa Cruz, was awarded one of three ... contracts with the goal of building a system ... Genome Atlas (TCGA) and other datasets by co-locating ... one cloud environment. This co-location will enable researchers ...
(Date:10/31/2014)... Daily Gossip writes in its Xtreme Fat ... the fastest fat loss program ever developed. It promises to ... , There is no wonder after all that this has ... The new nutrition and workout fat loss program was created ... , According to the author of this fat loss system, ...
(Date:10/31/2014)... October 31, 2014 This Method ... amazing health effects for practitioners. , The ... Doctor of Science and Movement specializing in physical ... to pelvic floor reeducation that traditional abdominal exercises ... Diastasis Recti, Prolepses, etc. , The Hipopressives exercises ...
Breaking Medicine News(10 mins):Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:Decoding the emergence of metastatic cancer stem cells 2Health News:Decoding the emergence of metastatic cancer stem cells 3Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 2Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 3Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 3
... Over Q1 2008VANCOUVER, April 20 /PRNewswire-FirstCall/ - Response ... preliminary unaudited revenues for the three-month period ended ... to approximately $2.526 million compared to $1.173 million ... the highest revenues for any quarter in the ...
... Intervention Will Retain Decision Resources, Clinical Gold Standard ... from Decision ResourcesWALTHAM, Mass., April 20 Decision ... advisory firms for pharmaceutical and healthcare issues, finds ... mortality as the attribute that most influences their ...
... Mix Featuring Arthur and Friends , BURLINGTON, Mass. ... Cherrybrook Kitchen, the brand known for allergy-friendly desserts and ... Arthur, the award-winning PBS character whose TV show entertains ... challenges, lessons and obstacles of growing up. Launched in ...
... largest Italian American Service Organization in the United States, ... Awardees will be honored at the 87th Annual UNICO ... Americanism Award: Grand Order Filippo Mazzei ... of the Adopt a Soldier Platoon Cianci Humanitarian ...
... Leukemia & Lymphoma SocietyWHITE PLAINS, N.Y., April 20 For ... perform on behalf of their children and other loved ones ... special to pay tribute to mothers.Consider the heroic gesture performed ... more terrifying for a mother than to watch helplessly as ...
... To Sleep products so much, we bought the company"MILWAUKEE, ... today that ICP has acquired Scent To Sleep - ... a revolutionary All Natural Non-Drowsy Sleep Mist ( www.ScentToSleep.com ... To Sleep products so much, we bought the company. ...
Cached Medicine News:Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 2Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 3Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 4Health News:For Reducing Mortality, Current and Emerging Therapies Have No Advantage Over Carvedilol in the Treatment of Coronary Heart Disease (Stable Angina) 2Health News:For Reducing Mortality, Current and Emerging Therapies Have No Advantage Over Carvedilol in the Treatment of Coronary Heart Disease (Stable Angina) 3Health News:Cherrybrook Kitchen Announces New Partnership With Arthur 2Health News:Cherrybrook Kitchen Announces New Partnership With Arthur 3Health News:UNICO National Announces 2009 Award Winners 2Health News:UNICO National Announces 2009 Award Winners 3Health News:This Mother's Day Celebrate a Mother's Love 2Health News:Scent To Sleep All Natural Non-Drowsy Sleep Mist Acquired by Innovative Custom Products, Inc. (ICP) 2
... Increase profitability by ... with simple test,sequences ... administered by ancillary ... than 5 minutes. ...
Holladay Contract Acuity Test provides a more sensitive evaluation for testing visual functions than standard acuity charts....
Vectograms are the standard for vision training. They are available in fixed or variable,styles to accommodate unlimited base-in and base-out training. Each vectogram,includes one pair,of standard 3-...
... Designed to Meet All ... Binocular Cross Cylinder Horizontal and ... Associated Phoria, Binocular Visual Acuity ... Range Monocular Cross Cylinder, Random ...
Medicine Products: